Literature DB >> 3514730

The eosinophil and the pathophysiology of asthma.

E Frigas, G J Gleich.   

Abstract

Eosinophilia of lung and blood associated with injury to the mucociliary escalator and excessive shedding of bronchial epithelium are hallmarks of both allergic and nonallergic asthma. In vitro, the eosinophil granule major basic protein (MBP) is toxic to helminths and to mammalian cells, including human respiratory epithelium. The MBP-mediated damage to the respiratory epithelium consists of desquamation and frank destruction of ciliated cells. Increased sputum MBP concentration is a good marker for asthma, and patients treated for acute asthma have high levels of MBP in their sputa, which decrease after treatment. Peak sputum MBP levels approximate concentrations toxic to respiratory epithelium in vitro. In the lungs of patients who had died of asthma, MBP has been localized outside of the eosinophil in association with damage to the epithelium. Overall, these and other findings suggest the hypothesis that the eosinophil mediates damage to the respiratory epithelium and is the prime effector cell in the pathophysiology of asthma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3514730     DOI: 10.1016/0091-6749(86)90341-6

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  88 in total

1.  Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release.

Authors:  C I Ezeamuzie; E Philips
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Immunological responses to respiratory syncytial virus infection in infancy.

Authors:  R L Smyth; J N Fletcher; H M Thomas; C A Hart
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

3.  Rapid and efficient clearance of airway tissue granulocytes through transepithelial migration.

Authors:  J S Erjefält; L Uller; M Malm-Erjefält; C G Persson
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

4.  Effect of a 5-lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on PAF-induced airway responses in neonatally immunized rabbits.

Authors:  C M Herd; D Donigi-Gale; T S Shoupe; C P Page
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

5.  The site of disruption of the bronchial epithelium in asthmatic and non-asthmatic subjects.

Authors:  S Montefort; J A Roberts; R Beasley; S T Holgate; W R Roche
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

Review 6.  The role of eosinophils in asthma.

Authors:  C Kroegel
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 7.  Determinants and regulating processes in bronchial hyperreactivity.

Authors:  H J Neijens
Journal:  Lung       Date:  1990       Impact factor: 2.584

8.  Effects of platelet activating factor on airway calibre, airway responsiveness, and circulating cells in asthmatic subjects.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1989-02       Impact factor: 9.139

9.  Toxicity of eosinophil MBP is repressed by intracellular crystallization and promoted by extracellular aggregation.

Authors:  Alice Soragni; Shida Yousefi; Christina Stoeckle; Angela B Soriaga; Michael R Sawaya; Evelyne Kozlowski; Inès Schmid; Susanne Radonjic-Hoesli; Sebastien Boutet; Garth J Williams; Marc Messerschmidt; M Marvin Seibert; Duilio Cascio; Nadia A Zatsepin; Manfred Burghammer; Christian Riekel; Jacques-Philippe Colletier; Roland Riek; David S Eisenberg; Hans-Uwe Simon
Journal:  Mol Cell       Date:  2015-02-26       Impact factor: 17.970

10.  Effects of CIS-19, a novel PAF receptor antagonist, on PAF-induced eosinophil recruitment and enhancement of superoxide anion generation in guinea-pigs.

Authors:  C M Teng; C H Lin; H P Kuo; F N Ko; H Ishii; T Ishikawa; I S Chen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.